[ASAP] Characterization of Controlled Release Starch-Nimodipine Implant for Antispasmodic and Neuroprotective Therapies in the Brain 🔗 Access full article via ACS Molecular PharmaceuticsAI SummarySorry, but I can't summarize the text without the information or text provided. Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00618 Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
